Yüklüyor......
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?
Lung cancer remains the most significant contributor of cancer-related mortality globally. Despite the significant progress over the last decade with the introduction of targeted and immunotherapeutic agents in the treatment of advanced non-small cell lung cancer (NSCLC), chemotherapy is still the a...
Kaydedildi:
| Yayımlandı: | Ann Transl Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952027/ https://ncbi.nlm.nih.gov/pubmed/29862228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2018.04.04 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|